Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Caplin Point Laboratories Limited

Market Cap 18TCr 185.03Cr 160.57Cr 148.01Cr 138.69Cr 259.12Cr 264.52Cr 1.77TCr 683.57Cr 8.54TCr 694.6Cr 679.63Cr 30TCr P/E Ratio 2026
17.9x
P/E Ratio 2027 * 24.8x
Enterprise Value 18TCr 185.03Cr 160.57Cr 148.01Cr 138.69Cr 259.12Cr 264.52Cr 1.77TCr 683.57Cr 8.54TCr 694.6Cr 679.63Cr 30TCr EV / Sales 2026
5.23x
EV / Sales 2027 * 7.12x
Free-Float
26.39%
Yield 2026 *
-
Yield 2027 * 0.17%
1 day+0.99%
1 week+15.69%
Current month+14.81%
1 month+25.75%
3 months+38.14%
6 months+19.38%
Current year+26.59%
1 week 2,006.45
Extreme 2006.45
2,407.2
1 month 1,806
Extreme 1806
2,407.2
Current year 1,502.45
Extreme 1502.45
2,407.2
1 year 1,502.45
Extreme 1502.45
2,407.2
3 years 781.25
Extreme 781.25
2,636
5 years 575
Extreme 575
2,636
10 years 180
Extreme 180
2,636
Manager TitleAgeSince
Chief Executive Officer 71 28/03/2015
Director of Finance/CFO - 19/02/2016
Chief Administrative Officer - -
Director TitleAgeSince
Chairman 73 27/01/2010
Director/Board Member - 05/11/2025
Director/Board Member 71 28/03/2015
Change 5-day change 1-year change 3-year change Capi.($)
+0.99%+15.69%+10.21%+191.24% 184.15Cr
+0.44%+0.79%+6.13%+82.35% 4.5TCr
+0.10%-3.31%+38.41%+87.81% 3.37TCr
+0.46%-1.10%-9.10%+42.72% 1.17TCr
+0.69%+1.96%+12.99%+117.80% 1.16TCr
0.00%+0.39%+36.53%+125.55% 894.45Cr
-1.44%-1.94%+15.12%+39.35% 700.72Cr
-1.27%-0.76%+39.84%-18.76% 651.35Cr
+0.00%-1.66%+31.13%+237.16% 635.21Cr
-0.45%-2.96%-39.97%-6.82% 514.7Cr
Average -0.05%+0.85%+14.13%+89.84% 1.38TCr
Weighted average by Cap. +0.13%-1.56%+16.82%+84.41%

Financials

2026 2027 *
Net sales 2.13TCr 22Cr 19Cr 18Cr 17Cr 31Cr 32Cr 212.06Cr 82Cr 1.03TCr 83Cr 82Cr 3.57TCr 2.49TCr 26Cr 23Cr 21Cr 19Cr 36Cr 37Cr 247.94Cr 96Cr 1.2TCr 98Cr 95Cr 4.17TCr
Net income 616.2Cr 6.44Cr 5.58Cr 5.15Cr 4.82Cr 9.01Cr 9.2Cr 61Cr 24Cr 297.03Cr 24Cr 24Cr 1.03TCr 712.75Cr 7.44Cr 6.46Cr 5.95Cr 5.58Cr 10Cr 11Cr 71Cr 28Cr 343.57Cr 28Cr 27Cr 1.19TCr
Net Debt - -
Logo Caplin Point Laboratories Limited
Caplin Point Laboratories Limited is an India-based pharmaceutical company with a business model catering predominantly to emerging markets of Latin America and Africa. The Company has also entered regulated markets such as the United States through its Subsidiary, Caplin Steriles Limited. The Company's operations include research & development and manufacturing of finished formulations, active pharmaceutical ingredients (APIs), clinical research, front-end generic presence in Latin America, brand marketing in Francophone Africa and a USFDA/EU-GMP approved injectable facility. In the Regulated Markets, its products include liquid & lyophilized vials, pre-filled syringes, three-pc ophthalmic droppers and pre-mix bags. In the Emerging Markets, its products include tablets, dry syrups - bottles, soft gels, capsules, suppositories, liquid syrups - bottles, liquid injectables in ampoules & vials, lyophilized vials, prefilled syringes (PFS), and emulsion injection in ampoules & vials.
Employees
3,966
Date Price Change Volume
11/26/11 2,330.80 +0.99% 14,610
10/26/10 2,308.00 +2.23% 77,262
09/26/09 2,257.60 +7.00% 29,424
08/26/08 2,110.00 +3.87% 19,801
05/26/05 2,031.45 +0.83% 3,609
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
2,330.80INR
Average target price
2,505.00INR
Spread / Average Target
+7.47%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 524742 Stock
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!